ArticleClinical lung cancer2013
Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.
Article in Clinical lung cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review.BMC cancer · 2019Pooled it
- The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers.Cancers · 2024Article
- Lung cancer in patients who have never smoked - an emerging disease.Nature reviews. Clinical oncology · 2024Review
- Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation.Frontiers in oncology · 2023Article
- A Case of Isolated Myeloid Sarcoma Associated With GermlineJournal of hematology · 2022Article
- A Germline Mutation in ATR Is Associated With Lung Adenocarcinoma in Asian Patients.Frontiers in oncology · 2022Article
- Presentation ofTranslational lung cancer research · 2021Article
- Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients.Frontiers in oncology · 2021Article
- Significant Benefits of Osimertinib Against Adenosquamous Carcinoma Harboring Germline T790M Mutation.The oncologist · 2020Article
- Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study.Cancer science · 2020Observational
- Inherited lung cancer: a review.Ecancermedicalscience · 2020Review
- Familial Lung Cancer: A Brief History from the Earliest Work to the Most Recent Studies.Genes · 2017Review
- Germline mutations predisposing to non-small cell lung cancer.Familial cancer · 2015Review
- Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.Frontiers in oncology · 2015Article
- Multiple Organ Lesions in a Case of Contamination With Multiple Radionuclides After 38 Years.Dose-response : a publication of International Hormesis SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.